Syneos Health Inc (SYNH) Stock
SYNH is no longer traded. Syneos Health was taken private by Elliott, Patient Square and Veritas on September 28, 2023.
Each SYNH share was exchanged for $43.00 in cash. Prices on this page are historical; the last trade was September 27, 2023 at $42.98.
Syneos Health stock price history
SYNH final trading statistics
- Final close
- $42.98
- Final trading day
- Sep 27, 2023
- Market cap at delisting
- $4.46B
- Shares outstanding
- 103.72M
- Final 52-week range
- $22.89 – $52.23
- Avg. volume (final 3 mo.)
- 1,391,744
- All-time high (split-adj.)
- $102.89 · Nov 2021
- All-time low (split-adj.)
- $20.49 · Nov 2014
- Return since IPO
- +109.8%
- Beta
- 1.58
- Book value / share
- $33.69
- Price / book
- 1.28
Syneos Health annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $5.39B | $266.5M | $4.72 |
| FY2021 | $5.21B | $234.8M | $4.46 |
| FY2020 | $4.42B | $192.8M | $3.41 |
| FY2019 | $4.68B | $131.3M | $3.23 |
| FY2018 | $4.39B | $24.3M | $2.87 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Syneos Health Inc
Syneos Health, Inc., operates as an integrated biopharmaceutical solutions company. The company operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in Phase I to IV of clinical development. This segment offers individual services, including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication; and consulting services. Its customers include companies in the biopharmaceutical, biotechnology, and medical device industries. It operates in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company has a strategic partnership with uMotif Limited to deliver patient-centric eClinical platform. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina. As of September 28, 2023, Syneos Health, Inc. was taken private.
Syneos Health stock FAQ
What happened to Syneos Health stock?
Syneos Health was taken private by Elliott, Patient Square and Veritas on September 28, 2023. Shareholders received $43.00 in cash for each share. SYNH stock stopped trading on the Nasdaq, with a final close of $42.98 on September 27, 2023.
What did Syneos Health shareholders receive?
Each SYNH share was converted into $43.00 in cash. The deal was valued at about $7.1 billion.
Is SYNH stock still trading?
No. SYNH was delisted from the Nasdaq on September 28, 2023 and no longer trades on a U.S. exchange.
What was the last price of SYNH stock?
SYNH closed at $42.98 on its final trading day, September 27, 2023, for a market value of about $4.46B.
What were Syneos Health's revenue and earnings in its last full fiscal year?
Syneos Health reported revenue of $5.39B and net income of $266.5M in fiscal 2022, its last full year as a public company.
When did Syneos Health go public?
Syneos Health Inc stock began trading on November 7, 2014.